Fresenius Medical Care AG (FMS) News & EventsFMSFresenius Medical Care AG

U.S. HHS Launches Kidney Care National Plan

The U.S. Department of Health and Human Services announced the launch of the "Kidney Care National Plan," which it calls "a coordinated department-wide strategy focused on revitalizing American kidney care." HHS stated: "As part of the Make America Healthy Again initiative, the new Kidney Care National Plan will address the root cause of disease and implement better treatments for Americans at every stage of kidney disease. The Plan identifies where federal action can improve kidney care across the entire spectrum of kidney disease, eliminate regulatory barriers to support innovation and a well-functioning kidney market, and deliver greater choice and superior outcomes to Americans." Publicly traded companies that may be impacted include DaVita (DVA), TransMedics (TMDX), and Fresenius Medical (FMS).

Trump Administration Proposes Kidney Care Plan to Boost Competition and Innovation

The Trump administration's proposed kidney care plan aims to boost competition and innovation while prioritizing preventive care to detect chronic kidney disease earlier and reduce costly, late-stage treatment, Caitlin Owens of Axios reports. The Trump administration's kidney care plan argues that consolidation in the dialysis market, where two chains control roughly 74% of the market, limits competition and enables dominant providers to charge higher prices. Publicly traded companies that may be impacted include DaVita (DVA), TransMedics (TMDX), and Fresenius Medical (FMS).